Template:Antiphospholipid syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


Antiphiospholipid syndrome Microchapters
Antiphospholipid syndrome Microchapters
'''
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
Line 10: Line 10:
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
[[Antiphiospholipid syndrome|Home]]
[[Antiphospholipid syndrome|Home]]
|-  
|-  
!
!
Line 16: Line 16:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome (patient information)|Patient Information]]
[[Antiphospholipid syndrome (patient information)|Patient Information]]
|-  
|-  
!
!
Line 22: Line 22:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome overview|Overview]]
[[Antiphospholipid syndrome overview|Overview]]
|-  
|-  
!
!
Line 28: Line 28:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome historical perspective|Historical Perspective]]
[[Antiphospholipid syndrome historical perspective|Historical Perspective]]
|-  
|-  
!
!
Line 34: Line 34:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome classification|Classification]]
[[Antiphospholipid syndrome classification|Classification]]
|-  
|-  
!
!
Line 40: Line 40:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome pathophysiology|Pathophysiology]]
[[Antiphospholipid syndrome pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 46: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome causes|Causes]]
[[Antiphospholipid syndrome causes|Causes]]
|-  
|-  
!
!
Line 52: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome differential diagnosis|Differentiating Antiphiospholipid syndrome from other Diseases]]
[[Antiphospholipid syndrome differential diagnosis|Differentiating Antiphospholipid syndrome from other Diseases]]
|-  
|-  
!
!
Line 58: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome epidemiology and demographics|Epidemiology and Demographics]]
[[Antiphospholipid syndrome epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 64: Line 64:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome risk factors|Risk Factors]]
[[Antiphospholipid syndrome risk factors|Risk Factors]]
|-  
|-  
!
!
Line 70: Line 70:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome screening|Screening]]
[[Antiphospholipid syndrome screening|Screening]]
|-  
|-  
!
!
Line 76: Line 76:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Antiphiospholipid syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]
[[Antiphospholipid syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 88: Line 88:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome diagnostic criteria|Diagnostic Criteria]]
[[Antiphospholipid syndrome diagnostic criteria|Diagnostic Criteria]]
|-  
|-  
!
!
Line 94: Line 94:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome history and symptoms|History and Symptoms]]
[[Antiphospholipid syndrome history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 100: Line 100:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome physical examination|Physical Examination]]
[[Antiphospholipid syndrome physical examination|Physical Examination]]
|-  
|-  
!
!
Line 106: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome laboratory findings|Laboratory Findings]]
[[Antiphospholipid syndrome laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 112: Line 112:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome electrocardiogram|Electrocardiogram]]
[[Antiphospholipid syndrome electrocardiogram|Electrocardiogram]]
|-  
|-  
!
!
Line 118: Line 118:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome chest x ray|Chest X Ray]]
[[Antiphospholipid syndrome chest x ray|Chest X Ray]]
|-  
|-  
!
!
Line 124: Line 124:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome CT|CT]]
[[Antiphospholipid syndrome CT|CT]]
|-  
|-  
!
!
Line 130: Line 130:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome MRI|MRI]]
[[Antiphospholipid syndrome MRI|MRI]]
|-  
|-  
!
!
Line 136: Line 136:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome echocardiography or ultrasound|Echocardiography or Ultrasound]]
[[Antiphospholipid syndrome echocardiography or ultrasound|Echocardiography or Ultrasound]]
|-  
|-  
!
!
Line 142: Line 142:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome other imaging findings|Other Imaging Findings]]
[[Antiphospholipid syndrome other imaging findings|Other Imaging Findings]]
|-  
|-  
!
!
Line 148: Line 148:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Antiphiospholipid syndrome other diagnostic studies|Other Diagnostic Studies]]
[[Antiphospholipid syndrome other diagnostic studies|Other Diagnostic Studies]]
|-  
|-  
!
!
Line 160: Line 160:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Antiphiospholipid syndrome medical therapy|Medical Therapy]]
[[Antiphospholipid syndrome medical therapy|Medical Therapy]]
|-  
|-  
!
!
Line 166: Line 166:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Antiphiospholipid syndrome surgery|Surgery]]
[[Antiphospholipid syndrome surgery|Surgery]]
|-  
|-  
!
!
Line 172: Line 172:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Antiphiospholipid syndrome primary prevention|Primary Prevention]]
[[Antiphospholipid syndrome primary prevention|Primary Prevention]]
|-  
|-  
!  
!  
Line 178: Line 178:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Antiphiospholipid syndrome secondary prevention|Secondary Prevention]]
[[Antiphospholipid syndrome secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!  
Line 184: Line 184:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Antiphiospholipid syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Antiphospholipid syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 190: Line 190:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Antiphiospholipid syndrome future or investigational therapies|Future or Investigational Therapies]]
[[Antiphospholipid syndrome future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!  
Line 202: Line 202:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Antiphiospholipid syndrome case study one|Case #1]]
[[Antiphospholipid syndrome case study one|Case #1]]
|-  
|-  
!
!
Line 303: Line 303:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Antiphiospholipid syndrome}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Antiphiospholipid syndrome]
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Antiphospholipid syndrome}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Antiphospholipid syndrome]
|-  
|-  
!  
!  

Revision as of 05:27, 31 August 2012